PositoAI/ US/ Q32 Bio Inc.

Q32 Bio Inc.

NasdaqCM: QTTB · Healthcare

Positivity Index

#1,336 / 6,774

Global

#283 / 4,000

United States

Positivity Score

22,927

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Q32 Bio Inc. — Overview & Financial Snapshot

Q32 Bio Inc. (NasdaqCM: QTTB) is a Healthcare company, ranked #1,336 of 6,774 companies globally and #283 of 4,000 in United States on PositoAI, with a Positivity Score of 22,927. Its market capitalisation is ₹2,472.77 Cr ($261.97M), P/E ratio is 2.8 and P/B ratio is 2.47. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

P/B Ratio 2.47

P/E Ratio 2.8

D/E Ratio 0.05

ROE 72.14%

Owes vs Owns ? 0.09× Low $0.09 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹297.33$3.15

Forward EPS ₹-96.28$-1.02

Beta -0.11

Market Cap ₹2,472.77 Cr$261.97M

What these numbers mean →

What does Q32 Bio Inc. do?

What is Q32 Bio Inc.'s P/E and P/B ratio?

Q32 Bio Inc. has a P/E ratio of 2.8 and a P/B ratio of 2.47.

What is Q32 Bio Inc.'s debt-to-equity ratio?

Q32 Bio Inc. has a debt-to-equity ratio of 0.05.

How much does Q32 Bio Inc. owe compared with what it owns?

Q32 Bio Inc. owes $0.09 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Q32 Bio Inc.'s Positivity rank?

Q32 Bio Inc. is ranked #1,336 of 6,774 companies globally and #283 of 4,000 in United States on PositoAI, with a Positivity Score of 22,927.

Does Q32 Bio Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Q32 Bio Inc..

Where can I read the latest news about Q32 Bio Inc.?

Recent headlines about Q32 Bio Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Q32 Bio Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Q32 Bio Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.